Medley has set its eyes on becoming a truly global pharmaceutical company over the next decade. Medley's products reach 24 countries with significant presence in Asia, Africa, Middle East, Russia and CIS Medley intend to enhance its International presence based on its policy of "Integrity in Medicines" and quality of products. Medley already has setup the office in UK and tied up with partner in USA and SA.
Medley is aggressively working on finalizing its business tie-ups in Brazil. Medley has dynamic team and representative office in Vietnam, Myanmar, Cambodia, Sri Lanka, Kenya, Russia, Kazakhstan Kyrgyzstan and Tajikistan. The dynamic field force promotes its speciality formulations. Around 514 formulations are registered in 26 countries. Today International business contributes 16% of Medley sales, but expected to grow substantially in the next three years. We have three manufacturing facilities, Daman, Tarapur and Jammu which strictly follows WHO GMP guidelines.
All our manufacturing facilities are the state of art manufacturing units for oral and liquid section. The Daman Facility is MHRA-UK approved. One of our facilities at DAMAN is certified for Good Manufacturing Practices (GMP) Conforming to INTERNATIONAL STANDARDS by Competent Regulatory Authorities in Uganda, Sudan, Tanzania, Malawi, Ethiopia, Yemen and Ivory Coast. Medley is now preparing for the South African MCC, ANVISA Brazil.
This initiative of Medley would help strive for the growth and to serve the world community.